{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.1/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Furosemide",
            "Path": "../../Furosemide-Model.json",
            "BuildingBlocks": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 7,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AxesSettings": {
            "ComparisonTimeProfile": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "µg/ml",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Unit": "µg/ml",
                    "Dimension": "Concentration (mass)",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "µg/ml",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "PKRatioPlots": [
                {
                    "Unit": "year(s)",
                    "Dimension": "Age",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "AllPlots": [
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 0.5 mgkg (bolus)_Alván 1988_1",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 20 mg (bolus)_Haegeli 2007_33+34",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 20 mg (bolus)_Rosenkranz 1992_66",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 22 mg (bolus)_Tilstone 1978_83",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (2 min)_Waller 1982_97",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (3 min)_Smith 1980_78+79",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_Andreasen 1977_9+10",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_González 1982_32",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_Hammarlund 1984_39+40",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_Homeida 1977_47",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_Keller 1981_52+53",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_Lambert 1983_58",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 80 mg (2 min)_Andreasen 1981_4",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 80 mg (2 min)_Andreasen 1983_7+8",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 80 mg (bolus)_Branch 1977_21+22",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 80 mg (bolus)_Kelly 1974_57",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 80 mg (bolus)_Rane 1978_65",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 40 mg (bolus)_Rupp 1974_67",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "i.v. 80 mg (bolus)_Verbeeck 1982_90+91",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 20 mg (-) q.d._Vaidyanathan 2008_89",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 20 mg (tab) q.d._FDA 2006_49",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab) q.d._FDA 2005_48",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 1  mg (sol)_Stopfer 2018_341+342",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 20  mg (sol)_Waller 1985_100+101",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40  mg (sol)_Waller 1985_102+103",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40  mg (sol)_Waller 1988_533+534",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (sol)_Waller 1982_99",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 44  mg (sol)_Tilstone 1978_84",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 5  mg (sol)_Stopfer 2016_167+168",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 80  mg (sol)_Kelly 1974_54",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 80  mg (sol)_Waller 1985_104+105",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 20 mg (tab)_Haegeli 2007_35+36",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Ballester 2015_13+14",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Bindschedler 1997_19+20",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Hammarlund 1984_41+42",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Martin 1984 - brand name tablet_59+60",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Martin 1984 - generic tablet_61+62",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Rakhit 1987_63+64",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Rupp 1974_68",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 80 mg (tab)_Kelly 1974_56",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 80 mg (tab)_Shoaf 2007_74+75",
                "SectionId": 331
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40 mg (tab)_Waller 1982_98",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 80 mg (tab)_Vree 1995_95+96",
                "SectionId": 332
            },
            {
                "Project": "Furosemide",
                "Simulation": "p.o., 40  mg (sol)_Wiebe 2020_521+522",
                "SectionId": 331
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plot for concentration in plasma.",
                "SectionId": 32,
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "Furosemide iv (model building)",
                        "Symbol": "Circle",
                        "OutputMappings": [

                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 20 mg (bolus)_Haegeli 2007_33+34",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Haegeli 2007_20_i.v._33",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_Keller 1981_52+53",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Keller 1981_40_i.v._52",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_Rupp 1974_67",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rupp 1974_40_i.v._67",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 80 mg (bolus)_Branch 1977_21+22",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Branch 1977_80_i.v._21",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 80 mg (bolus)_Verbeeck 1982_90+91",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Verbeeck 1982_80_i.v._90",
                                "Color": "#000000"
                            }
                        ]
                    },
                    {
                        "Caption": "Furosemide oral administration (model building)",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 1  mg (sol)_Stopfer 2018_341+342",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Stopfer 2018 - reference - Mean_1_p.o._341",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 5  mg (sol)_Stopfer 2016_167+168",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Stopfer 2016 - reference - Mean_5_p.o._167",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (sol)_Waller 1982_99",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1982_40_p.o._99",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40  mg (sol)_Waller 1985_102+103",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1985_40_p.o._102",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40  mg (sol)_Wiebe 2020_521+522",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Wiebe 2020 - 40 mg - Mean_40_p.o._521",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Bindschedler 1997_19+20",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bindschedler 1997_40_p.o._19",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Martin 1984 - brand name tablet_59+60",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Martin 1984 - brand-name tablet_39.6_p.o._59",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Martin 1984 - generic tablet_61+62",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Martin 1984 - generic tablet_40.3_p.o._61",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 80 mg (tab)_Shoaf 2007_74+75",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Shoaf 2007_80_p.o._74",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab) q.d._FDA 2005_48",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA 2005 _40_p.o._48",
                                "Color": "#000000"
                            }
                        ]
                    },{
                        "Caption": "Furosemide iv (model verification)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 20 mg (bolus)_Rosenkranz 1992_66",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rosenkranz 1992_20_i.v._66",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 22 mg (bolus)_Tilstone 1978_83",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Tilstone 1978_22_i.v._83",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_Andreasen 1977_9+10",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andreasen 1977_40_i.v._9",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_González 1982_32",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "González 1982_40_i.v._32",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_Hammarlund 1984_39+40",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hammarlund 1984_40_i.v._39",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_Homeida 1977_47",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Homeida 1977_40_i.v._47",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (bolus)_Lambert 1983_58",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Lambert 1986_40_i.v._58",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (2 min)_Waller 1982_97",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1982_40_i.v._97",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 40 mg (3 min)_Smith 1980_78+79",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Smith 1980a_40_i.v._78",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 80 mg (bolus)_Kelly 1974_57",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kelly 1974_80_i.v._57",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 80 mg (bolus)_Rane 1978_65",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rane 1978_80_i.v._65",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "i.v. 80 mg (2 min)_Andreasen 1983_7+8",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Andreasen 1983_80_i.v._7",
                                "Color": "#000000"
                            }

                        ]
                    },{
                        "Caption": "Furosemide oral administration (model verification)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 20  mg (sol)_Waller 1985_100+101",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1985_20_p.o._100",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 20 mg (tab)_Haegeli 2007_35+36",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Haegeli 2007_20_p.o._35",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 20 mg (tab) q.d._FDA 2006_49",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA 2006_20_p.o._49",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 20 mg (-) q.d._Vaidyanathan 2008_89",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vaidyanathan 2008_20_p.o._89",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40  mg (sol)_Waller 1988_533+534",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1988_Furosemide_40_p.o._533",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Ballester 2015_13+14",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Ballester 2015_40_p.o._13",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Hammarlund 1984_41+42",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hammarlund 1984_40_p.o._41",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Rakhit 1987_63+64",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rakhit 1987_40_p.o._63",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 44  mg (sol)_Tilstone 1978_84",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Tilstone 1978_44_p.o._84",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 80  mg (sol)_Kelly 1974_54",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kelly 1974_80_p.o._54_solution",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 80  mg (sol)_Waller 1985_104+105",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1985_80_p.o._104",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Waller 1982_98",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Waller 1982_40_p.o._98",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 80 mg (tab)_Kelly 1974_56",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kelly 1974_80_p.o._56_tablet",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 80 mg (tab)_Vree 1995_95+96",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Vree 1995_80_p.o._95",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Furosemide",
                                "Simulation": "p.o., 40 mg (tab)_Rupp 1974_68",
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Rupp 1974_40_p.o._68",
                                "Color": "#000000"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Furosemide",
            "Name": "Furosemide",
            "Type": "Compound",
            "SectionId": 31
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Content": "Content/Section2.1_Modeling_Strategy.md",
                    "Title": "Modeling strategy"
                },
                {
                    "Id": 22,
                    "Content": "Content/Section2.2_Data.md",
                    "Title": "Data used"
                },
                {
                    "Id": 23,
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md",
                    "Title": "Model parameters and assumptions"
                }
            ]
        },
        {
            "Id": 3,
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Title": "Results and Discussion",
            "Sections": [
                {
                    "Id": 31,
                    "Content": "Content/Input_table.md",
                    "Title": "Furosemide final input parameters"
                },
                {
                    "Id": 32,
                    "Content": "Content/GOF_diagnostics.md",
                    "Title": "Furosemide Diagnostics Plots"
                },
                {
                    "Id": 33,
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Id": 332,
                            "Title": "Model Verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 4,
            "Content": "Content/Section4_Conclusion.md",
            "Title": "Conclusion"
        },
        {
            "Id": 5,
            "Content": "Content/References.md",
            "Title": "References"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}
